Ottobre 2018 - Volume XXXVII - numero 8

Medico e Bambino


L’epidemiologia che “conta” nelle scelte vaccinali:
il caso della pertosse in neonati e lattanti

Federico Marchetti1, Claudia Guiducci2, Raffaella Angelini3

1UOC di Pediatria e Neonatologia, Ospedale di Ravenna, AUSL della Romagna
2Scuola di Specializzazione in Pediatria, Università di Ferrara
3Dipartimento di Sanità Pubblica, AUSL della Romagna

Indirizzo per corrispondenza:

Epidemiology that “counts” in vaccination choices: the case of pertussis in newborns and infants

Key words: Pertussis, Infant, Maternal pertussis vaccination, Efficacy

From June to August 2018, 6 infants with pertussis aged between 1 and 9 months (4 were 3 months old, and the other two 1 month and 9 months old respectively) were admitted to a General Paediatrics Operating Unit. Their hospitalization period lasted between 3 and 11 days (mean 7.2 days). Three infants required oxygen therapy. No complications occurred. None of the mothers had been offered vaccination against pertussis during pregnancy. The epidemiology of pertussis is changing in Italy as well as in other countries with high vaccination coverage. The disease is now increasing as an incidence in adolescents (and adults) who have lost their immune protection, and especially in new-born infants who have not started or completed the primary vaccination course yet. The data from the European Annual Epidemiological Report for 2016 report the highest notification rate in children <1 year (73.6 cases per 100,000 population), similar to that observed in 2015 (73.1). The vaccination of pregnant women against pertussis is considered an effective and available preventive option adopted for some years and in a systematic way in different international contexts. Also in Italy, in the 2017-2019 National Vaccination Plan there is a recommendation to recall in pregnancy the immunization from pertussis with the trivalent vaccine (whooping cough, tetanus and diphtheria). The period indicated is between the 27th and the 36th week, ideally around the 28th week. The vaccine strategy for pertussis in pregnant women is effective in reducing neonatal deaths due to the disease, the need for hospitalization and the severity of the infection in infants under the age of 3 months. The vaccine does not pose any risk for pregnant women and newborns. Pertussis prevention in newborns and infants is an urgent measure of public health.

Vuoi citare questo contributo?

F. Marchetti, C. Guiducci, R. Angelini
L’epidemiologia che “conta” nelle scelte vaccinali:; il caso della pertosse in neonati e lattanti
Medico e Bambino 2018;37(8):495-500

L'accesso è riservato agli abbonati alla rivista che si siano registrati.
Per accedere all'articolo in formato full text è necessario inserire username e password.
Puoi accedere all'articolo abbonandoti alla rivista (link). Per acquistare l'articolo contattare la redazione all'indirizzo